LATEST
Nobel Peace Prize Laureate Urges Israelis to Act Over Gaza Genocide as American Jewish Dissent DeepensTerry Dubrow: “You Can’t Trust Every Company Selling GLP-1 Drugs Online.” So He Founded One.Pia and Joshua Filler Introduce KillerFillers Jump, Break, and Jump/Break Tip Line Developed with TitlistA2C and Andrea Pusateri Bring “Here for the Ride” to Sardinia for a Five-Stage Grand Loop Cycling ChallengeCoatingSolution4U Launches First Commercial PlasticXpert Service at CEPLAA Hospital Bombed, a Population Trapped: Gaza’s Ceasefire of ImpunityLife Science Company OZQA Challenges Traditional Quality Management Consultancy with Ready-To-Implement QMS SolutionsCharities and Broadband Providers Unite to Call for New Approach to Ensure Nobody Is Priced Out of ConnectivityIsrael Hires Conservative Data Broker for $500,000 Campaign to Reshape US OpinionNo Thanks: The Palestinian Developer Who Turned Family Loss in Gaza into a Global Boycott AppNobel Peace Prize Laureate Urges Israelis to Act Over Gaza Genocide as American Jewish Dissent DeepensTerry Dubrow: “You Can’t Trust Every Company Selling GLP-1 Drugs Online.” So He Founded One.Pia and Joshua Filler Introduce KillerFillers Jump, Break, and Jump/Break Tip Line Developed with TitlistA2C and Andrea Pusateri Bring “Here for the Ride” to Sardinia for a Five-Stage Grand Loop Cycling ChallengeCoatingSolution4U Launches First Commercial PlasticXpert Service at CEPLAA Hospital Bombed, a Population Trapped: Gaza’s Ceasefire of ImpunityLife Science Company OZQA Challenges Traditional Quality Management Consultancy with Ready-To-Implement QMS SolutionsCharities and Broadband Providers Unite to Call for New Approach to Ensure Nobody Is Priced Out of ConnectivityIsrael Hires Conservative Data Broker for $500,000 Campaign to Reshape US OpinionNo Thanks: The Palestinian Developer Who Turned Family Loss in Gaza into a Global Boycott App
Business

Promis Neurosciences to Present at the H.C. Wainwright 25Th Annual Global Investment Conference

Richard Powell  1 min read

ProMIS Neurosciences Inc. (Nasdaq: PMN), a biotechnology company focused on the generation and development of antibody therapeutics targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA), today announced that Gail Farfel, Ph.D., Chief Executive Officer and Larry Altstiel, M.D., Ph.D., Chief Medical Officer of ProMIS Neurosciences, will present at the upcoming H.C. Wainwright 25th Annual Global Investment Conference on Tuesday, September 12, 2023 at 4:30 p.m. ET in New York, NY.

A live webcast of their presentation may be accessed by visiting the Events page of the Company’s website at http://www.promisneurosciences.com, and will be available for at least 30 days following the event.

ProMIS Neurosciences Inc. is a clinical stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). The Company’s proprietary target discovery engine is based on the use of two complementary techniques. The Company applies its thermodynamic, computational discovery platform – ProMIS and Collective Coordinates – to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins. Using this unique approach, the Company is developing novel antibody therapeutics for AD, ALS and MSA. ProMIS has offices in Toronto, Ontario and Cambridge, Massachusetts. ProMIS is listed on Nasdaq under the symbol PMN.

http://www.promisneurosciences.com.

Related articles

Top